BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23745996)

  • 1. Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis.
    Cantarini L; Lucherini OM; Vitale A; Sabadini L; Brizi MG; Frediani B; Muscari I; Galeazzi M
    Intern Med J; 2013 Jun; 43(6):725-7. PubMed ID: 23745996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Baldari CT; Laghi Pasini F; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(3):405-7. PubMed ID: 20497634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome.
    Cantarini L; Lucherini OM; Cimaz R; Baldari CT; Bellisai F; Rossi Paccani S; Laghi Pasini F; Capecchi PL; Sebastiani GD; Galeazzi M
    Int J Immunopathol Pharmacol; 2009; 22(4):1051-8. PubMed ID: 20074469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent pericarditis: autoimmune or autoinflammatory?
    Maestroni S; Di Corato PR; Cumetti D; Chiara DB; Ghidoni S; Prisacaru L; Cantarini L; Imazio M; Penco S; Pedrotti P; Caforio AL; Doria A; Brucato A
    Autoimmun Rev; 2012 Nov; 12(1):60-5. PubMed ID: 22884556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
    Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
    Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study.
    Cantarini L; Lucherini OM; Brucato A; Barone L; Cumetti D; Iacoponi F; Rigante D; Brambilla G; Penco S; Brizi MG; Patrosso MC; Valesini G; Frediani B; Galeazzi M; Cimaz R; Paolazzi G; Vitale A; Imazio M
    Clin Res Cardiol; 2012 Jul; 101(7):525-31. PubMed ID: 22311714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mutation (T61I) in the gene encoding tumour necrosis factor receptor superfamily 1A (TNFRSF1A) in a Japanese patient with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) associated with systemic lupus erythematosus.
    Ida H; Kawasaki E; Miyashita T; Tanaka F; Kamachi M; Izumi Y; Huang M; Tamai M; Origuchi T; Kawakami A; Migita K; Motomura M; Yoshimura T; Eguchi K
    Rheumatology (Oxford); 2004 Oct; 43(10):1292-9. PubMed ID: 15280569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment.
    Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M
    Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Symptoms related to tumor necrosis factor receptor 1-associated periodic syndrome, multiple sclerosis, and severe rheumatoid arthritis in patients carrying the TNF receptor superfamily 1A D12E/p.Asp41Glu mutation.
    Havla J; Lohse P; Gerdes LA; Hohlfeld R; Kümpfel T
    J Rheumatol; 2013 Mar; 40(3):261-4. PubMed ID: 23322460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
    Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
    Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel mutations in TNFRSF1A in patients with typical tumor necrosis factor receptor-associated periodic syndrome and with systemic lupus erythematosus in Japanese.
    Horiuchi T; Tsukamoto H; Mitoma H; Miyagawa H; Tamimoto Y; Yoshizawa S; Harada M; Hayashi K; Hashimura C; Oribe M; Okamura S
    Int J Mol Med; 2004 Nov; 14(5):813-8. PubMed ID: 15492850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of anakinra in an adult patient with recurrent pericarditis and cardiac tamponade as initial manifestations of tumor necrosis factor receptor-associated periodic syndrome due to the R92Q TNFRSF1A variant.
    Camprubí D; Mitjavila F; Arostegui JI; Corbella X
    Int J Rheum Dis; 2017 Apr; 20(4):510-514. PubMed ID: 27990755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recurrent pericarditis caused by a rare mutation in the TNFRSF1A gene and with excellent response to anakinra treatment.
    Cantarini L; Lucherini OM; Cimaz R; Galeazzi M
    Clin Exp Rheumatol; 2010; 28(5):802. PubMed ID: 21029567
    [No Abstract]   [Full Text] [Related]  

  • 14. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation.
    Kümpfel T; Hoffmann LA; Rübsamen H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Arthritis Rheum; 2007 Aug; 56(8):2774-83. PubMed ID: 17665448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling of tumor necrosis factor receptor superfamily 1A mutants associated with tumor necrosis factor receptor-associated periodic syndrome indicates misfolding consistent with abnormal function.
    Rebelo SL; Bainbridge SE; Amel-Kashipaz MR; Radford PM; Powell RJ; Todd I; Tighe PJ
    Arthritis Rheum; 2006 Aug; 54(8):2674-87. PubMed ID: 16871532
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophils from patients with TNFRSF1A mutations display resistance to tumor necrosis factor-induced apoptosis: pathogenetic and clinical implications.
    D'Osualdo A; Ferlito F; Prigione I; Obici L; Meini A; Zulian F; Pontillo A; Corona F; Barcellona R; Di Duca M; Santamaria G; Traverso F; Picco P; Baldi M; Plebani A; Ravazzolo R; Ceccherini I; Martini A; Gattorno M
    Arthritis Rheum; 2006 Mar; 54(3):998-1008. PubMed ID: 16508982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution.
    Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U
    Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
    Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
    J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant forms of tumour necrosis factor receptor I that occur in TNF-receptor-associated periodic syndrome retain signalling functions but show abnormal behaviour.
    Todd I; Radford PM; Draper-Morgan KA; McIntosh R; Bainbridge S; Dickinson P; Jamhawi L; Sansaridis M; Huggins ML; Tighe PJ; Powell RJ
    Immunology; 2004 Sep; 113(1):65-79. PubMed ID: 15312137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases.
    Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P
    Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.